Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis

Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis

The COVID-19 pandemic has redemonstrated the importance of the fungal-after-viral phenomenon, and the question of whether prophylaxis should be used to prevent COVID-19-associated pulmonary aspergillosis (CAPA). A distinct pathophysiology from invasive pulmonary aspergillosis (IPA), CAPA has an inci...

Full description

Bibliographic Details
Main Authors: Armani M. Hawes, Nitipong Permpalung
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Antibiotics
Subjects:
CAPA
fungal prophylaxis
COVID-19
aspergillosis
Online Access:https://www.mdpi.com/2079-6382/11/12/1704

Internet

https://www.mdpi.com/2079-6382/11/12/1704

Similar Items